Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic Stroke

Bibliographic Details
Main Author: Santos, Maria Beatriz
Publication Date: 2023
Other Authors: Rodrigues, Alexandra, Ferreira, Patrícia, Paiva Nunes, Ana
Format: Article
Language: por
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: https://doi.org/10.24950/rspmi.1602
Summary: Introduction: The stroke prevention strategy in patients with intracerebral hemorrhage (ICH) and atrial fibrillation (AF) is a clinical dilemma. The aim of this study was to evaluate themanagement of anticoagulation therapy in patients with AFand admitted with ICH. Methods: We performed a descriptive analysis of patientsadmitted for ICH from 2009 to 2021. Data collection was carried out by consulting the processes and analyzing demographic, clinical and imaging data, and prior and post-discharge therapy. A comparative analysis of outcomes of anticoagulant therapy was performed between direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs). Results: A total of 28 patients (22 male patients; median age 75 years) were included in the study, of which 19 were previously on anticoagulation therapy. Only eight (re)startedanticoagulation after discharge. There were 19 deaths, of which 17 were in the group without post-discharge anticoagulation; of those, five occurred in the first month after ICH. Discussion: There was strong concordance between BFFA and culture for detection of bacteria. In fact, most bacteria (76/106 [72%]) detected by BFFA were also identified in culture. In other hand, it is relevant that only one negative BFPP had an isolated agent in the cultural exam. Conclusion: Most patients did not (re)initiate anticoagulationafter ICH, despite being a high-risk group for new cerebrovascular events, which makes the discussion on this topic evenmore relevant. There was a change in the prescription pattern from VKAs to DOACs, comparing the two periods analyzed.
id RCAP_de7ac1f88faf74ffdb9752ba58a3d500
oai_identifier_str oai:oai.revista.spmi.pt:article/1602
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic StrokeHipocoagulação em Doentes com Fibrilhação Auricular e Internados por AVC HemorrágicoAcidente Vascular Cerebral HemorrágicoAnticoagulantesFibrilação AuricularAnticoagulantsAtrial FibrillationHemorrhagic StrokeIntroduction: The stroke prevention strategy in patients with intracerebral hemorrhage (ICH) and atrial fibrillation (AF) is a clinical dilemma. The aim of this study was to evaluate themanagement of anticoagulation therapy in patients with AFand admitted with ICH. Methods: We performed a descriptive analysis of patientsadmitted for ICH from 2009 to 2021. Data collection was carried out by consulting the processes and analyzing demographic, clinical and imaging data, and prior and post-discharge therapy. A comparative analysis of outcomes of anticoagulant therapy was performed between direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs). Results: A total of 28 patients (22 male patients; median age 75 years) were included in the study, of which 19 were previously on anticoagulation therapy. Only eight (re)startedanticoagulation after discharge. There were 19 deaths, of which 17 were in the group without post-discharge anticoagulation; of those, five occurred in the first month after ICH. Discussion: There was strong concordance between BFFA and culture for detection of bacteria. In fact, most bacteria (76/106 [72%]) detected by BFFA were also identified in culture. In other hand, it is relevant that only one negative BFPP had an isolated agent in the cultural exam. Conclusion: Most patients did not (re)initiate anticoagulationafter ICH, despite being a high-risk group for new cerebrovascular events, which makes the discussion on this topic evenmore relevant. There was a change in the prescription pattern from VKAs to DOACs, comparing the two periods analyzed.Introdução: A estratégia de prevenção secundária em doentes com acidente vascular cerebral hemorrágico (AVCh) e fibrilhação auricular (FA) é um dilema clínico. O objetivo dos autores foi avaliar a introdução ou manutenção de terapêutica hipocoagulante em doentes com FA e internados por AVCh. Métodos: Análise descritiva dos doentes internados por AVCh de 2009 a 2021. Foi feita a colheita de dados pelaconsulta dos processos e analisados dados demográficos, clínicos, imagiológicos e a terapêutica prévia e após alta.Realizou-se uma análise comparativa da terapêutica hipocoagulante entre anticoagulantes orais diretos (DOAC) e antagonistas da vitamina K (AVK). Resultados: Este estudo incluiu 104 pacientes, com idade média de 62 anos. O BFFA foi positivo em 111/125 (88%) dasamostras colhidas. As bactérias mais comummente detetadas foram Staphylococcus aureus (19%), Klebsiella pneumonia (14%) e Haemophilus influenza (10%). Discussão: Um total de 28 doentes (22 do género masculino; mediana de idade de 75 anos) foram incluídos no estudo, dos quais 19 eram hipocoagulados previamente. Destes, oito (re)iniciaram a hipocoagulação após a alta. Verificou-se o óbito em 19 doentes, dos quais 17 pertenciam ao grupo sem hipocoagulação após alta e destes, cinco óbitos foram verificados no primeiro mês após o AVCh. Conclusão: A maioria dos doentes não (re)iniciou hipocoagulação após AVCh, apesar de serem um grupo de alto risco para novos eventos cerebrovasculares, o que torna a discussão sobre este tema ainda mais relevante. Assistiu-se a uma mudança no padrão de prescrição de AVK para DOAC, comparando os dois períodos em análise.Sociedade Portuguesa de Medicina Interna2023-12-15info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.24950/rspmi.1602https://doi.org/10.24950/rspmi.1602Internal Medicine; Vol. 30 No. 4 (2023): Outubro/Dezembro; 216-221Medicina Interna; Vol. 30 N.º 4 (2023): Outubro/Dezembro; 216-2212183-99800872-671Xreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAPporhttps://revista.spmi.pt/index.php/rpmi/article/view/1602https://revista.spmi.pt/index.php/rpmi/article/view/1602/1836Direitos de Autor (c) 2023 Medicina Internainfo:eu-repo/semantics/openAccessSantos, Maria BeatrizRodrigues, AlexandraFerreira, PatríciaPaiva Nunes, Ana2023-12-16T06:15:47Zoai:oai.revista.spmi.pt:article/1602Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T11:48:55.475204Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic Stroke
Hipocoagulação em Doentes com Fibrilhação Auricular e Internados por AVC Hemorrágico
title Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic Stroke
spellingShingle Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic Stroke
Santos, Maria Beatriz
Acidente Vascular Cerebral Hemorrágico
Anticoagulantes
Fibrilação Auricular
Anticoagulants
Atrial Fibrillation
Hemorrhagic Stroke
title_short Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic Stroke
title_full Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic Stroke
title_fullStr Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic Stroke
title_full_unstemmed Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic Stroke
title_sort Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic Stroke
author Santos, Maria Beatriz
author_facet Santos, Maria Beatriz
Rodrigues, Alexandra
Ferreira, Patrícia
Paiva Nunes, Ana
author_role author
author2 Rodrigues, Alexandra
Ferreira, Patrícia
Paiva Nunes, Ana
author2_role author
author
author
dc.contributor.author.fl_str_mv Santos, Maria Beatriz
Rodrigues, Alexandra
Ferreira, Patrícia
Paiva Nunes, Ana
dc.subject.por.fl_str_mv Acidente Vascular Cerebral Hemorrágico
Anticoagulantes
Fibrilação Auricular
Anticoagulants
Atrial Fibrillation
Hemorrhagic Stroke
topic Acidente Vascular Cerebral Hemorrágico
Anticoagulantes
Fibrilação Auricular
Anticoagulants
Atrial Fibrillation
Hemorrhagic Stroke
description Introduction: The stroke prevention strategy in patients with intracerebral hemorrhage (ICH) and atrial fibrillation (AF) is a clinical dilemma. The aim of this study was to evaluate themanagement of anticoagulation therapy in patients with AFand admitted with ICH. Methods: We performed a descriptive analysis of patientsadmitted for ICH from 2009 to 2021. Data collection was carried out by consulting the processes and analyzing demographic, clinical and imaging data, and prior and post-discharge therapy. A comparative analysis of outcomes of anticoagulant therapy was performed between direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs). Results: A total of 28 patients (22 male patients; median age 75 years) were included in the study, of which 19 were previously on anticoagulation therapy. Only eight (re)startedanticoagulation after discharge. There were 19 deaths, of which 17 were in the group without post-discharge anticoagulation; of those, five occurred in the first month after ICH. Discussion: There was strong concordance between BFFA and culture for detection of bacteria. In fact, most bacteria (76/106 [72%]) detected by BFFA were also identified in culture. In other hand, it is relevant that only one negative BFPP had an isolated agent in the cultural exam. Conclusion: Most patients did not (re)initiate anticoagulationafter ICH, despite being a high-risk group for new cerebrovascular events, which makes the discussion on this topic evenmore relevant. There was a change in the prescription pattern from VKAs to DOACs, comparing the two periods analyzed.
publishDate 2023
dc.date.none.fl_str_mv 2023-12-15
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.24950/rspmi.1602
https://doi.org/10.24950/rspmi.1602
url https://doi.org/10.24950/rspmi.1602
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revista.spmi.pt/index.php/rpmi/article/view/1602
https://revista.spmi.pt/index.php/rpmi/article/view/1602/1836
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2023 Medicina Interna
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2023 Medicina Interna
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Medicina Interna
publisher.none.fl_str_mv Sociedade Portuguesa de Medicina Interna
dc.source.none.fl_str_mv Internal Medicine; Vol. 30 No. 4 (2023): Outubro/Dezembro; 216-221
Medicina Interna; Vol. 30 N.º 4 (2023): Outubro/Dezembro; 216-221
2183-9980
0872-671X
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833592263822802944